Convertible Preferred Stock (Tables)

12 Months Ended

Dec. 31, 2021

Blade Therapeutics, Inc. [Member]

Convertible Preferred Stock (Tables) [Line Items]

Schedule of convertible preferred stock

	December 31, 2020
	Shares Authorized	Shares Outstanding	Price Per Share		Liquidation Preference		Proceeds, Net Issuance Cost
	(in thousands, except shares and original issue price)
Series A	6,500,000	6,500,000	$	1.00	$	6,500	$	6,341
Series B	43,000,000	40,369,153	$	1.055		42,589		42,335
Series C	62,156,880	22,642,414	$	1.141		25,835		25,596
Series C-1	22,000,000	13,533,123	$	1.141		15,441		14,835
Total	133,656,880	83,044,690			$	90,365	$	89,107

	December 31, 2021
	Shares Authorized	Shares Outstanding	Price Per Share		Liquidation Preference		Proceeds, Net Issuance Cost
	(in thousands, except shares and original issue price)
Series A	6,500,000	6,500,000	$	1.00	$	6,500	$	6,341
Series B	43,000,000	40,369,153	$	1.055		42,589		42,335
Series C	79,685,364	22,642,414	$	1.141		25,835		25,596
Series C-1	22,000,000	13,533,123	$	1.141		15,441		14,835
Total	151,185,364	83,044,690			$	90,365	$	89,107